Domestic Total: 73.79M
Opening Weekend: 39.01M
Legs: 2.04
Overview: Dangerously ill with a rare blood disorder, and determined to save others suffering his same fate, Dr. Michael Morbius attempts a desperate gamble. What at first appears to be a radical success soon reveals itself to be a remedy potentially worse than the disease.
| Date | Revenue | % YD | Theaters |
|---|---|---|---|
| Thu, Mar 31, 2022 | $5,700,000 | + 0.00% | 3583 |
| Fri, Apr 1, 2022 | $17,305,908 | + 203.61% | 4268 |
| Sat, Apr 2, 2022 | $13,148,513 | -24.02% | 4268 |
| Sun, Apr 3, 2022 | $8,551,474 | -34.96% | 4268 |
| Mon, Apr 4, 2022 | $2,126,392 | -75.13% | 4268 |
| Tue, Apr 5, 2022 | $2,706,560 | + 27.28% | 4268 |
| Wed, Apr 6, 2022 | $1,664,589 | -38.50% | 4268 |
| Thu, Apr 7, 2022 | $1,373,785 | -17.47% | 4268 |
| Fri, Apr 8, 2022 | $2,895,931 | + 110.80% | 4268 |
| Sat, Apr 9, 2022 | $4,476,758 | + 54.59% | 4268 |
| Sun, Apr 10, 2022 | $2,828,643 | -36.81% | 4268 |
| Mon, Apr 11, 2022 | $836,236 | -70.44% | 4268 |
| Tue, Apr 12, 2022 | $952,084 | + 13.85% | 4268 |
| Wed, Apr 13, 2022 | $748,787 | -21.35% | 4268 |
| Thu, Apr 14, 2022 | $802,471 | + 7.17% | 4268 |
| Fri, Apr 15, 2022 | $1,568,282 | + 95.43% | 3462 |
| Sat, Apr 16, 2022 | $1,973,419 | + 25.83% | 3462 |
| Sun, Apr 17, 2022 | $1,188,447 | -39.78% | 3462 |
| Mon, Apr 18, 2022 | $564,356 | -52.51% | 3462 |
| Tue, Apr 19, 2022 | $495,844 | -12.14% | 3462 |
| Wed, Apr 20, 2022 | $394,388 | -20.46% | 3462 |
| Thu, Apr 21, 2022 | $325,237 | -17.53% | 3462 |
| Fri, Apr 22, 2022 | $652,201 | + 100.53% | 2306 |
| Sat, Apr 23, 2022 | $1,016,024 | + 55.78% | 2306 |
| Sun, Apr 24, 2022 | $638,912 | -37.12% | 2306 |
| Mon, Apr 25, 2022 | $180,217 | -71.79% | 2306 |
| Tue, Apr 26, 2022 | $217,522 | + 20.70% | 2306 |
| Wed, Apr 27, 2022 | $170,136 | -21.78% | 1726 |
| Thu, Apr 28, 2022 | $154,231 | -9.35% | 1726 |
| Fri, Apr 29, 2022 | $392,649 | + 154.59% | 1726 |
| Sat, Apr 30, 2022 | $686,898 | + 74.94% | 1726 |
| Sun, May 1, 2022 | $433,794 | -36.85% | 1726 |
| Mon, May 2, 2022 | $142,753 | -67.09% | 1726 |
| Tue, May 3, 2022 | $151,435 | + 6.08% | 1726 |
| Wed, May 4, 2022 | $118,971 | -21.44% | 1726 |
| Thu, May 5, 2022 | $48,916 | -58.88% | 1726 |
| Fri, May 6, 2022 | $200,078 | + 309.02% | 1726 |
| Sat, May 7, 2022 | $301,589 | + 50.74% | 1726 |
| Sun, May 8, 2022 | $128,373 | -57.43% | 1726 |
| Mon, May 9, 2022 | $35,420 | -72.41% | 1726 |
| Tue, May 10, 2022 | $41,165 | + 16.22% | 1726 |
| Wed, May 11, 2022 | $32,913 | -20.05% | 1726 |
| Thu, May 12, 2022 | $28,536 | -13.30% | 1726 |
| Fri, May 13, 2022 | $113,324 | + 297.13% | 313 |
| Sat, May 14, 2022 | $147,638 | + 30.28% | 313 |
| Sun, May 15, 2022 | $44,847 | -69.62% | 313 |
| Mon, May 16, 2022 | $12,552 | -72.01% | 313 |
| Tue, May 17, 2022 | $11,618 | -7.44% | 313 |
| Wed, May 18, 2022 | $11,894 | + 2.38% | 313 |
| Thu, May 19, 2022 | $15,197 | + 27.77% | 313 |
| Fri, May 20, 2022 | $62,633 | + 312.14% | 207 |
| Sat, May 21, 2022 | $70,535 | + 12.62% | 207 |
| Sun, May 22, 2022 | $49,897 | -29.26% | 207 |
| Mon, May 23, 2022 | $9,374 | -81.21% | 207 |
| Tue, May 24, 2022 | $9,844 | + 5.01% | 207 |
| Wed, May 25, 2022 | $8,530 | -13.35% | 207 |
| Thu, May 26, 2022 | $5,327 | -37.55% | 207 |
| Fri, May 27, 2022 | $8,320 | + 56.19% | 83 |
| Sat, May 28, 2022 | $12,473 | + 49.92% | 83 |
| Sun, May 29, 2022 | $9,009 | -27.77% | 83 |
| Mon, May 30, 2022 | $5,558 | -38.31% | 83 |
| Tue, May 31, 2022 | $3,319 | -40.28% | 83 |
| Wed, Jun 1, 2022 | $3,037 | -8.50% | 83 |
| Thu, Jun 2, 2022 | $2,626 | -13.53% | 83 |
| Fri, Jun 3, 2022 | $88,625 | + 3274.90% | 1037 |
| Sat, Jun 4, 2022 | $132,459 | + 49.46% | 1037 |
| Sun, Jun 5, 2022 | $89,581 | -32.37% | 1037 |
| Mon, Jun 6, 2022 | $47,203 | -47.31% | 1037 |
| Tue, Jun 7, 2022 | $57,182 | + 21.14% | 1037 |
| Wed, Jun 8, 2022 | $44,118 | -22.85% | 1037 |
| Thu, Jun 9, 2022 | $15,515 | -64.83% | 1037 |
| Name | Character |
|---|---|
| Jared Leto | Dr. Michael Morbius |
| Matt Smith | Milo |
| Adria Arjona | Martine Bancroft |
| Jared Harris | Dr. Emil Nicholas |
| Tyrese Gibson | Agent Simon Stroud |
| Al Madrigal | Agent Rodriguez |
| Michael Keaton | Adrian Toomes |
| Zaris-Angel Hator | Anna |
| Joe Ferrara | Bush Pilot |
| Charlie Shotwell | Young Michael |
| Joseph Esson | Young Milo |
| Jason Rennie | Ringleader Bully |
| Aryan Moaven | Gang Member |
| Christopher Louridas | Gang Member |
| Oliver Bodur | Gang Member |
| Tom Forbes | Finance Bro (Pub) |
| Clara Rosager | Jean (Pub) |
| Corey Johnson | Mr. Fox |
| Rolan Bell | Private Security Professional |
| Bentley Kalu | Private Security Professional |
| Joanna Burnett | Nurse Kristen Sutton |
| Fermin Galeano | Bodega Owner |
| Maia Scalia | Diner Cashier |
| Archie Renaux | Bobby |
| Jojo Macari | Gabriel |
| Abraham Popoola | Ryan |
| Adam El Hagar | Beat Cop |
| Apphia Campbell | ESU Officer (Detention Center) |
| Barry Aird | Newspaper Vendor |
| Kalle Hennie | Norwegian Bodyguard |
| Chris Ryman | Officer Dyson |
| Jay Gomez-Adams | Construction Worker |
| Robert Ryan | Kite Flyer (uncredited) |
| Philip Gascoyne | NY Businessman (uncredited) |
Comps are similar or comparison movies that are used for analysis and marketing purposes. The way they are found is described in more detail in the paper. Comps always have release dates before the movie they are compared to.
| Title | Release Date | Budget |
|---|---|---|
| Venom: Let There Be Carnage | Sep 30, 2021 | $110M |
| Spider-Man: Far From Home | Jun 28, 2019 | $160M |
| Venom | Sep 28, 2018 | $116M |
| Spider-Man: No Way Home | Dec 15, 2021 | $200M |
| Spider-Man: Homecoming | Jul 5, 2017 | $175M |
| Ghost in the Shell | Mar 29, 2017 | $110M |
| X-Men: Apocalypse | May 18, 2016 | $178M |
| Pacific Rim: Uprising | Mar 21, 2018 | $150M |
Week 1: $51.2M
Week 2: $14.11M
Investor Share: $7.76M
Week 3+: $14.18M
Investor Share: $7.09M
$88.89M (52.79%)
Investor Share: $31.11M
Budget: $75M
P&A: $75M
Gross: $162.69M
Net: $76.69M
Costs: $150M
Profit: $-73.31M (Loss)
The profitability breakdown is based on Dan Murrell's YouTube videos (Dan Murrell is not affiliated with Reel Numbers). The breakdown only includes the theatrical release and does not account for any post-theatrical revenue streams such as streaming, home video, or merchandise sales. Additionally, the breakdown does not include any tax incentives, sponsorships, or product placement that may have occurred during production.